More clues to the relationship between hepatic iron and steatosis: An association with insulin resistance?

Gastroenterology

Volumn 117, Issue 5, 1999, Pages 1241-1244

  Macdonald, G A ^a   Powell, L W ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; IRON;

BIOACCUMULATION; DISEASE ASSOCIATION; EDITORIAL; HUMAN; INSULIN RESISTANCE; IRON OVERLOAD; IRON STORAGE; LIPID STORAGE; LIVER HISTOLOGY; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STEATOSIS;

EID: 0032742595     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70412-9     Document Type: Editorial

References (28)

1. J Ludwig TR Viggiano DB McGill BJ. Oh Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 5 1980 434 438
2. EE Powell WG Cooksley R Hanson J Searle JW Halliday LW. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
3. DK George S Goldwurm GA Macdonald LL Cowley NI Walker PJ Ward EC Jazwinska LW. Powell Increased hepatic iron stores in non-alcoholic steatohepatitis is associated with increased hepatic fibrosis Gastroenterology 114 1998 311 318
4. BR Bacon MJ Farahvash CG Janney BA. Neuschwander Tetri Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103 1109
5. M-H Mendler B Turlin R Moirand A-M Jouanolle T Sapey D Guyader J-Y Le Gall P Brissot V David Y Deugnier Insulin resistance–associated hepatic iron overload Gastroenterology 117 1999 1155 1163
6. JM Fernandez Real W Ricart Engel E Arroyo R Balanca R Casamitjana Abella D Cabrero M Fernandez Castaner J. Soler Serum ferritin as a component of the insulin resistance syndrome Diabetes Care 21 1998 62 68
7. PA Merkel DC Simonson SA Amiel G Plewe RS Sherwin HA Pearson WV. Tamborlane Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion N Engl J Med 318 1988 809 814
8. P Cavallo Perin G Pacini F Cerutti A Bessone C Condo L Sacchetti A Piga G. Pagano Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia Metabolism 44 1995 281 286
9. TP Tuomainen K Nyyssonen R Salonen A Ter vahauta H Korpela T Lakka GA Kaplan JT. Salonen Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men Diabetes Care 20 1997 426 428
10. H Knobler A Schattner T Zhornicki SD Malnick D Keter N Sokolovskaya Y Lurie DD Bass Fatty liver—an additional and treatable feature of the insulin resistance syndrome QJM 92 1999 73 79
11. P Marceau S Biron FS Hould S Marceau S Simard SN Thung JG. Kral Liver pathology and the metabolic syndrome X in severe obesity J Clin Endocrinol Metab 84 1999 1513 1517
12. NM. Kaplan The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension Arch Intern Med 149 1989 1514 1520
13. Consensus Development Conference on Insulin Resistance American Diabetes Association. Diabetes Care 21 November 5–6, 1997. 310 314
14. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report Obes Res 6 suppl 2 1998 51s 209s National Institutes of Health
15. L Mykkanen SM Haffner T Ronnemaa RN Bergman M. Laakso Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors Am J Epidemiol 146 1997 315 321
16. MK Mau A Grandinetti RF Arakaki HK Chang EK Kinney JD. Curb The insulin resistance syndrome in native Hawaiians. Native Hawaiian Health Research (NHHR) Project Diabetes Care 20 1997 1376 1380
17. KM Flegal MD Carroll RJ Kuczmarski CL Johnson Overweight and obesity in the United States: prevalence and trends, 1960–1994 Int J Obes Relat Metab Disord 22 1998 39 47
18. JP Despres S Moorjani PJ Lupien A Tremblay A Nadeau C. Bouchard Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease Arteriosclerosis 10 1990 497 511
19. JG Kral F Schaffner RN Pierson Jr J. Wang Body fat topography as an independent predictor of fatty liver Metabolism 42 1993 548 551
20. KJ Greenlund R Valdez ML Casper S Rith Najarian JB. Croft Prevalence and correlates of the insulin resistance syndrome among Native Americans. The Inter-Tribal Heart Project Diabetes Care 22 1999 441 447
21. T Goto T Onuma K Takebe JG. Kral The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects Int J Obes Relat Metab Disord 19 1995 841 855
22. MA Banerji MC Buckley RL Chaiken D Gordon HE Lebovitz JG. Kral Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM Int J Obes Relat Metab Disord 19 1995 846 850
23. DH Crawford EC Jazwinska LM Cullen LW. Powell Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation Gastroenterology 114 1998 1003 1008
24. BR Bacon JK Olynyk EM Brunt RS Britton RK. Wolf f HFE genotype in patients with hemochromatosis and other liver diseases Ann Intern Med 130 1999 953 962
25. FS. Facchini Effect of phlebotomy on plasma glucose and insulin concentrations (letter) Diabetes Care 21 1998 2190
26. IM Hramiak DT Finegood PC. Adams Factors affecting glucose tolerance in hereditary hemochromatosis Clin Invest Med 20 1997 110 118
27. LF Hourigan GA Macdonald D Purdie VH Whitehall C Shorthouse A Clouston EE. Powell Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1999 1215 1219
28. S Naveau V Giraud E Borotto A Aubert F Capron JC. Chaput Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111